Richard Maurice Walmsley
Founder at Gentronix Ltd.
Richard Maurice Walmsley active positions
| Companies | Position | Start | End |
|---|---|---|---|
Gentronix Ltd.
 Gentronix Ltd. BiotechnologyHealth Technology Gentronix Ltd. provides services and solutions to help organizations optimize the development of drugs and other chemicals. It provides contract services for genotoxicity using a patented human cell GADD45a reporter GreenScreen HC and BlueScreen HC assays and related assays including Micronucleus and Ames MPF. The company was founded by Richard Maurice Walmsley in July 1999 and is headquartered in Macclesfield, the United Kingdom. | Chief Tech/Sci/R&D Officer | 31/12/1998 | - |
| Founder | 21/03/2010 | - | |
| University of Manchester Institute of Science & Technology | Corporate Officer/Principal | - | - |
Career history of Richard Maurice Walmsley
Training of Richard Maurice Walmsley
| University of Kent | Doctorate Degree |
Statistics
International
| United Kingdom | 4 |
Operational
| Chief Tech/Sci/R&D Officer | 1 |
| Founder | 1 |
| Corporate Officer/Principal | 1 |
Sectoral
| Consumer Services | 3 |
| Health Technology | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 1 |
|---|---|
Gentronix Ltd.
Gentronix Ltd. BiotechnologyHealth Technology Gentronix Ltd. provides services and solutions to help organizations optimize the development of drugs and other chemicals. It provides contract services for genotoxicity using a patented human cell GADD45a reporter GreenScreen HC and BlueScreen HC assays and related assays including Micronucleus and Ames MPF. The company was founded by Richard Maurice Walmsley in July 1999 and is headquartered in Macclesfield, the United Kingdom. | Health Technology |
